Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: Relationship to metabolic parameters and diabetic complications

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 12, Issue 3, 2002, Pages 127-131

  Tarkun, I ^a,b   Cetinarslan B ^a   Canturk Z ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b Yahya Kaptan Mah   (Turkey)

Author keywords

Cardiovascular disease; Diabetes mellitus; Diabetic proliferative retinopathy; Lipoprotein(a)

Indexed keywords

BIOLOGICAL MARKER; LIPOPROTEIN A;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETIC NEUROPATHY; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0036617957     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barry S, Horowitz H, Ginsberg N (1998) Dyslipidemia. Current Management of Diabetes Mellitus. In: DeFronzo RA (ed), Mosby-Year Book, St.Louis, pp 123-133
2. Niskanen L, Mykkanen L, Karonen SL, Uusitupa M (1993) Apoprotein (a) levels in relation to coronary heart disease and risk factors in type II diabetics. Cardiovasc Risk Factors 13: 205-210
3. Erem C, Deger O, Bostan M, Örem A, Sönmez M, Ulusoy S, Telatar M (1999) Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications. Acta Cardiol 54: 203-207
4. McLean JW, Tomlinson JE, Kuang WJ (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330: 132-137
5. Uterman G, Weber W (1987) Protein composition of lipoprotein (a). J Clin Invest 80:458-465
6. Dahlen GH (1994) Lp(a) in cardiovascular disease. Atherosclerosis 108: 111-126
7. Hiraga T, Kobayashi T, Okuba M, Nakanishi K, Sugimato T, Ohashi Y (1995) Prospective study of lipoprotein (a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 18: 241-244
8. Haffner SM, Klein BE, Moss SE, Klein R (1995) Lp(a) is not related to retinopathy in diabetic subjects. Eur J Ophthalmol 5: 119-123
9. Hoefler G, Harnoncourt F, Paschke E, Kostner GM (1988) Lipoprotein (a): A risk factor for myocardial infarction. Arteriosclerosis 8: 398-401
10. Sandkamp M, Funke H, Schulte H, Köhler E, Assman G (1990) Lipoprotein (a) is an independent risk factor for myocardial infarction at young age. Clin Chem 36: 20-23
11. Chico A, Perez A, Caixas A, Ordonez J, Pou JM, de Leiva A (1996) Lipoprotein (a) concentrations and non-insulin-dependent diabetes mellitus: relationship to glycaemic control and diabetic complications. Diabetes Res Clin Pract 33: 105-110
12. Scanu AM, Scandian L (1991) Lipoprotein (a); structure, biology and clinical relevance. Adv Intern Med 36: 249-270
13. Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD (1992) Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35: 1055-1059
14. Velho G, Erlich D, Tuppin E, Neel D, Cohen D (1992) Lipoprotein (a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care 16: 742-747
15. Haffner SM, Moss SE, Klein BE, Klein R (1992) Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism 41: 194-197
16. Wollesen F, Dahlen G, Berglund L, Berne C (1999) Peripheral atherosclerosis and serum lipoprotein (a) in diabetes. Diabetes Care 22: 93-99
17. Watts GF, Gwilym RM, Mazurkiewicz J, Coltart J (1995) Independent correlation between plasma lipoprotein (a) and angiographic coronary artery disease in NIDDM. Diabetes Care 8: 234-236
18. Yamamoto M, Egusa G, Yamakido M (1997) Carotid atherosclerosis and serum lipoprotein (a) concentrations in patients with NIDDM. Diabetes Care 20: 829-831
19. Haffner SM, Morales PA, Stern MP, Gruber MK (1992) Lp(a) concentrations in NIDDM. Diabetes 41: 1267-1272
20. Chico A, Perez A, Caixas A, Ordonez J, Pou JM, de Leiva A (1996) Lipoprotein (a) concentrations and non-insulin dependent diabetes mellitus: relationship to glycaemic control and diabetic complications. Diabetes Res Clin Pract 33: 105-110
21. Durlach V, Gillery P, Bertin E, Grulet H, Gross A, Leutenerger M (1998) Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients. Diabetes Metab 23: 124-130
22. Durlach V, Gillery P, Bertin E, Grulet H, Gross A, Leutenerger M (1996) Serum lipoprotein (a) concentrations in a population of 819 non-insulin dependent diabetic patients. Diabetes Metab 22: 319-323
23. Hirata K, Kikuchi S, Saku K, Jimi S, Zhang B (1993) Apolipoprotein (a) phenotypes and serum lipoprotein (a) levels in maintainance hemodialysis patients with/without diabetes mellitus. Kidney Int 44: 1062-1070
24. Maser RE, Usher D, Becker DJ, Drash AL , Kuller LH, Orchard TJ (1993) Lipoprotein (a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort. Diabetes Care 16: 755-758
25. Willems D, Dorchy H, Dufrasne D (1996) Serum lipoprotein (a) in type I diabetic children and adolescents: relationship with HbA1c and subclinical complications. Eur J Pediatr 155: 175-178
26. Kim CH, Park HJ, Park JY, Hong SK, Yoon YH, Lee KU (1998) High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy. Diabetes Care 21: 2149-2151
27. Morisaki N, Yokote K, Tashiro J, Inadera H, Kobayashi J (1994) Lipoprotein (a) is a risk factor for diabetic retinopathy in the elderly. J Am Geriatr Soc 42: 965-967
28. Heesen BJ, Wolffrnbuttel BH, Leurs PB, Sels JP, Menheere PP (1993) Lipoprotein(a) levels in relation to diabetic complications in patients with NIDDM. Eur J Clin Invest 23: 580-584
29. Guerci B, Meye L, Sommer S, George JL, Ziegler O, Drouin P, Angio-Duprez K (1999) Severity of diabetic retinopathy is linked to lipoprotein (a) in type I diabetic patients. Diabetes Metab 25: 412-418
30. Gazzurusa C, Garzaniyi A, Buscaglia P (1998) Lipoprotein (a) levels and apolipoprotein (a) polymorphism in type I diabetes mellitus; relationship to microvascular and neurological complications. Acta Diabetol 35: 13-18
31. Hajjar KA, Gavish D, Breslow JL, Nachman RL (1989) Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339: 303-305
32. Westerhuis LW, Venekamp VJ (1996) Serum lipoprotein (a) and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus. Clin Biochem 29: 255-259